USE OF LOW DOSE ARGININE VASOPRESSIN TO SUPPORT BRAIN-DEAD ORGAN DONORS
Stephen H. Pennefather(North Tyneside General Hospital), John H. Dark(University of Michigan), David Mantle(Pharma Nord (United Kingdom)), R. Bullock(North Tyneside General Hospital)
Cited by 169
Related Papers
Oxidative damage to protein in sporadic motor neuron disease spinal cord
|Annals of Neurology|1995|326
Elevated Levels of Interleukin-8 in Donor Lungs is Associated with Early Graft Failure after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2001|262
Comparison of relative antioxidant activities of British medicinal plant species in vitro
|Journal of Ethnopharmacology|2000|211
Muscle growth in response to mechanical stimuli
|American Journal of Physiology-Endocrinology and Metabolism|1995|198
Disorders of Human Coenzyme Q10 Metabolism: An Overview
|International Journal of Molecular Sciences|2020|181